









Markets
/
Stocks
/
nasdaq-nivf
/

NewGenIvf Group Ltd

NIVF

0.634USD

+0.025+4.11%

Close 11/04, 16:00（ET）Quotes delayed by 15 min

548.35KMarket Cap

LossP/E TTM



NewGenIvf Group Ltd

0.634

+0.025+4.11%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of NewGenIvf Group Ltd

Currency: USD Updated: 2025-11-04

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered undervalued,and institutional recognition is low. Over the past 30 days, multiple analysts have rated the company as a .

NewGenIvf Group Ltd's Score

Industry at a Glance

Industry Ranking

66 / 78

Overall Ranking

529 / 4616

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 0 analysts

Current Rating

15.000

Target Price

+2363.05%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

NewGenIvf Group Ltd Highlights

StrengthsRisks

NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. The Company offers services, such as Mitochondrial Replacement Therapy In Reproductive, Intrauterine Insemination (IUI), Mitochondrial replacement therapy (MRT) techniques, In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI), semen analysis, testicular / epididymal sperm aspiration or extraction / percutaneous epididymal sperm aspiration, embryo transfer, chromosome screening and egg freezing. The Company’s clinics are located in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. MRT involves an additional egg from a third person, and manipulating both the recipient egg and the donor egg.

Growing

The company is in a growing phase, with the latest annual income totaling USD 5.43M.

Turnaround to Loss

The company's performance has turned to a loss, with the latest annual loss of USD .

Fairly Valued

The company’s latest PE is 0.02, at a medium 3-year percentile range.

Institutional Buying

The latest institutional holdings are 5.48K shares, increasing 22.58% quarter-over-quarter.

Held by Howard Marks

Star Investor Howard Marks holds 0.00 shares of this stock.

Financial Health

Currency: USD Updated: 2025-11-04

The company's current financial score is 5.95, which is lower than the Healthcare Providers & Services industry's average of 7.24. Its financial status is weak, and its operating efficiency is low.

Score

Industry at a Glance

Previous score

5.95

Change



Financials

4.73

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

10.00

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

2.51

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

5.44

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.09

Key Metrics

Free cash flow

No Data

NewGenIvf Group Ltd's Company Valuation

Currency: USD Updated: 2025-11-04

The company’s current valuation score is 7.62, which is higher than the Healthcare Providers & Services industry's average of 7.09. Its current P/E ratio is 0.02, which is 4432196.31% below the recent high of 961.81 and 1134805.99% above the recent low of -246.23.

Score

Industry at a Glance

Previous score

7.62

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 66/78

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-04

There is no earnings forecast score for this company; the Healthcare Providers & Services industry's average is 7.56. The average price target for NewGenIvf Group Ltd is 15.00, with a high of 15.00 and a low of 15.00.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

No Data

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-04

There is no price momentum score for this company; the Healthcare Providers & Services industry's average is 7.02.

Score

Industry at a Glance

Previous score

1.18

Change

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.154

Sell

RSI(14)

22.777

Sell

STOCH(KDJ)(9,3,3)

6.274

Oversold

ATR(14)

0.291

Low Volatility

CCI(14)

-179.932

Sell

Williams %R

97.193

Oversold

TRIX(12,20)

-2.409

Sell

StochRSI(14)

12.497

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

0.847

Sell

MA10

1.033

Sell

MA20

1.357

Sell

MA50

1.683

Sell

MA100

1.420

Sell

MA200

7.253

Sell

Institutional Confidence

Currency: USD Updated: 2025-11-04

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Providers & Services industry's average of 6.96. The latest institutional shareholding proportion is 0.30%, representing a quarter-over-quarter decrease of 77.09%. The largest institutional shareholder is Howard Marks, holding a total of 0.00 shares, representing 0.00% of shares outstanding, with 1.00% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

JAK Opportunities VI LLC

14.59K

Fong (Wai Lam Tina)

2.33K

Marex Group plc

2.01K

Siu (Wing Fung Alfred)

1.78K

Chardan Capital Markets, LLC

1.57K

ATW Spac Management LLC

1.13K

White Lion Capital LLC

700.00

Sze (Kit Yee)

547.00

UBS Financial Services, Inc.

70.00

SBI Securities Co., Ltd.

2.00

Risk Assessment

Currency: USD Updated: 2025-11-04

The company’s current risk assessment score is 1.16, which is lower than the Healthcare Providers & Services industry's average of 5.44. The company's beta value is -0.13. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.